TAD, sildenafil and vardenafil are employed to treat erectile dysfunction (ED) through the specific inhibition of cGMP-specific PDE5, responsible for cGMP degradation in the corpus cavernosum [43]. This evidence concerns the gene PDE5A and erectile dysfunction.